October 23, 2021

Biology Reporter

Complete News World

USA: COVID-19 drug significantly reduces risk of death

USA: COVID-19 drug significantly reduces risk of death

The company said it will soon apply for approval of the drug in the US market. If the company gets approval, the world’s first anti-COVID-19 drug will be available to patients. Merck said it will begin talks with the US Food and Drug Administration (FDA) in the coming days.

Dr. Dean Lee, Research Associate at Merc & Co. said: – When you see 50 percent and added that the decrease in hospitalizations or deaths means that the drug has great clinical potential.

Merck Pill interacts with the coronavirus enzyme, which is responsible for transcribing and reproducing the genetic code. The tablet also works similarly to other viruses.

In clinical trials, both those who received the trial pill and the placebo reported side effects. The company did not provide any further details, but only said that more reports of side effects came from the placebo group.

The US government has announced that it will purchase 1.7 million doses of the drug if it is approved for use by the Food and Drug Administration. Merck said it will be able to produce 10 million doses of molnopiravir by the end of the year. The price of the tablet is not yet known.

Pharmaceutical companies Pfizer and Roche Holding AG are also working on a drug for COVID-19.

We are glad you are with us. Subscribe to the Onet newsletter to receive the most valuable content from us.

(pmd)

See also  We will pay a heavy price for printing money. Will there be tax increases?